Jefferies raises Pfizer (NYSE:PFE) price target from $38 to $39

By / / Pfizer

Jefferies analyst Akash Tewari upgrades Pfizer (NYSE:PFE) from Hold to Buy and raises the price target from $38 to $39.

Scroll to Top